LCM
EW icon

Laurion Capital Management’s Edwards Lifesciences EW Stock Holding History

Laurion Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,000
Closed -$2.74M – 793
2020
Q4 		$2.74M Buy
+30,000
New +$2.49M 0.02% 313
2020
Q1 		– Sell
-118,200
Closed -$9.19M – 855
2019
Q4 		$9.19M Buy
+118,200
New +$9.23M 0.07% 230
2019
Q1 		– Sell
-210,900
Closed -$10.8M – 970
2018
Q4 		$10.8M Sell
210,900
-40,200
-16% -$2.03M 0.19% 143
2018
Q3 		$14.6M Buy
+251,100
New +$12.3M 0.14% 162

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Laurion Capital Management's EW Position: Q3 2025 in Review

Laurion Capital Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 3,186 shares — an estimated $249K sold.

Laurion Capital Management first reported a position in EW in Q1 2016 and held it in 12 quarters. The position peaked at $34.1M in Q4 2020. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Laurion Capital Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 3,186 Edwards Lifesciences shares in Q3 2025, an estimated $249K.
  • Laurion Capital Management first reported a position in Edwards Lifesciences in Q1 2016 and held it in 12 quarters.
  • Laurion Capital Management's Edwards Lifesciences position peaked at $34.1M in Q4 2020.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.